Article info
PDFGTN
Five-Day Intravascular Methotrexate Versus Biweekly Actinomycin-D in the Treatment of Low-Risk Gestational Trophoblastic Neoplasia: A Clinical Randomized Trial
- Address correspondence and reprint requests to Khadijeh Adabi, Moheb Yas Women General Hospital, North Ostad Nejatolahi Avenue, Karim Khan Street, Tehran, Iran, Postcode 1598718311. E-mail: khadabi{at}yahoo.com.
Citation
Five-Day Intravascular Methotrexate Versus Biweekly Actinomycin-D in the Treatment of Low-Risk Gestational Trophoblastic Neoplasia: A Clinical Randomized Trial
Publication history
- Received November 2, 2015
- Accepted January 17, 2016
- First published June 1, 2016.
Online issue publication
June 18, 2019
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© 2016 by the International Gynecologic Cancer Society and the European Society of Gynaecological Oncology.